Skip to content

A STUDY on the PREVALENCE of METABOLIC DISEASES IN PATIENTS with PSORIASIS

A Study on the Presence of Metabolic Syndrome and its association in patients with Psoriasis : A tertiary care hospital study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027675
Enrollment
250
Registered
2020-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Criteria for including patients in the study include patients who are freshly diagnosed cases of psoriasis in both sexes, age >18 years, and willingness of the patients to participate in the study.

Exclusion criteria

Exclusion criteria: Patients Those unwilling to participate or Those who have been receiving any systemic therapy for psoriasis 1 month before enrollment will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To establish the presence of MS in patients with Psoriasis and proportion of psoriasis patients with MS in the sample population To prove the fact that Psoriasis is associated with metabolic disorders such as hypertension, type II diabetes mellitus, dyslipidemia, abdominal obesity, insulin resistance, cardiac disorders and the risk of metabolic syndrome is increased. For helping in initating preventive measures to prevent risk of cardiovascular events in later lifeTimepoint: The proportion of psoriatic patients with metabolic syndrome when 50 percent of sample size is estimated The Risk of cardiovascular and cerebrovascular disease Requirements for any risk modifiable therapy

Secondary

MeasureTime frame
To establish the presence of MS in patients with Psoriasis and proportion of psoriasis patients with MS in the sample population â?¢ To prove the fact that Psoriasis is associated with metabolic disorders such as hypertension, type II diabetes mellitus, dyslipidemia, abdominal obesity, insulin resistance, cardiac disorders and the risk of metabolic syndrome is increased. â?¢ For helping in initating preventive measures to prevent risk of cardiovascular events in later lifeTimepoint: The proportion of psoriatic patients with metabolic syndrome when 50 percent of sample size is estimated The Risk of cardiovascular and cerebrovascular disease Requirements for any risk modifiable therapy

Countries

India

Contacts

Public ContactMAHAD HASAN KHAN

Kasturba Medical College

ba.shastry@manipal.edu9845702450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026